BIOMAT Database Logo BIOMAT Database Logo

[Growth hormone level during stimulation tests and efficacy of growth hormone therapy in children with growth hormone insufficiency and idiopathic short stature]. 1993

M B Ranke, and O Gilbod

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin
D013268 Stimulation, Chemical The increase in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Stimulation,Chemical Stimulations,Stimulations, Chemical

Related Publications

M B Ranke, and O Gilbod
Growth hormone therapy in children with idiopathic short stature.
September 2002, Archives of pediatrics & adolescent medicine,
M B Ranke, and O Gilbod
Growth hormone in children with idiopathic short stature.
March 2011, BMJ (Clinical research ed.),
M B Ranke, and O Gilbod
Efficacy of short-term growth hormone treatment in prepubertal children with idiopathic short stature.
January 2014, Yonsei medical journal,
M B Ranke, and O Gilbod
Which children with idiopathic short stature should receive growth hormone therapy?
March 2008, Nature clinical practice. Endocrinology & metabolism,
M B Ranke, and O Gilbod
Growth hormone use in children with idiopathic short stature.
September 2004, The Annals of pharmacotherapy,
M B Ranke, and O Gilbod
Growth hormone therapy and children with idiopathic short stature: a viable option?
January 1999, Pediatric nursing,
M B Ranke, and O Gilbod
Growth response of Egyptian children with idiopathic short stature during four years of growth hormone therapy.
September 2011, Indian journal of human genetics,
M B Ranke, and O Gilbod
Immunologic studies in children with idiopathic short stature before and during growth hormone therapy. Dutch Growth Hormone Working Group.
January 1995, Hormone research,
M B Ranke, and O Gilbod
Moral assessment of growth hormone therapy for children with idiopathic short stature.
October 1997, Journal of medical ethics,
M B Ranke, and O Gilbod
Growth hormone (GH) determinations by RIA and IFA during GH stimulation tests in children with short stature.
November 2006, Georgian medical news,
Copied contents to your clipboard!